OncoSec Medical (ONMA) Q2 2023 Earnings Report
DE:ONMA Q2 2023 EPS Results
- Actual EPS
- -EUR 2.32
- Consensus EPS
- -EUR 25.23
- Beat/Miss
- Beat by +EUR 22.92
- One Year Ago EPS
- -EUR 4.80
DE:ONMA Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 03/15/2023
- Time
- TBA
- Conference Call
- Wednesday, March 15, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ONMA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 12, 2025 | 2025 (Q2) | ―- | ― | ― | |
| Mar 13, 2024 | 2024 (Q2) | ―- | ― | ― | |
| Jun 15, 2023 | 2023 (Q3) | -14.83- | -3.07 | ― | |
| Mar 15, 2023 | 2023 (Q2) | -25.23-2.32 | -4.8 | 51.78% (+2.49) | |
| Jun 14, 2022 | 2022 (Q3) | -3.07-3.07 | -4.8 | 36.00% (+1.73) | |
| Mar 15, 2022 | 2022 (Q2) | -3.46-4.80 | -7.14 | 32.73% (+2.34) | |
| Oct 28, 2019 | 2019 (Q4) | ―-14.60 | -46.1 | 68.33% (+31.50) | |
| Jun 14, 2019 | 2019 (Q3) | ―-19.78 | -38.42 | 48.50% (+18.63) | |
| Mar 08, 2019 | 2019 (Q2) | ―-25.55 | -49.94 | 48.85% (+24.39) | |
| Dec 14, 2018 | 2019 (Q1) | ―-26.89 | -47.06 | 42.86% (+20.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
